Li et al. demonstrated that silencing the CYP2S1 gene activated the MAPK/ERK-AHR signaling axis and triggered the apoptotic program of cancer cells in the context of BRAFV600E mutation, which significantly inhibited the proliferation, invasion, migration, and tumorigenicity of thyroid cancer cells 9. The gene discussed is CYP2S1; the disease is cancer.